Skip to content
777 Sourcing.

Capability

AI-based drug re-innovation

Suppliers
1
States & provinces
1
Countries
1

1 ai-based drug re-innovation supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

BIOXCEL THERAPEUTICS, INC.

NEW HAVEN, CT

BioXcel Therapeutics, Inc. is a biopharmaceutical company traded on Nasdaq under the symbol BTAI. It describes itself as pursuing AI-based Drug Re-innovation and maintains a pipeline and products, including IGALMI, a registered trademark of BioXcel Therapeutics, Inc. The company has an affiliate, OnkosXcel Therapeutics, and conducts clinical research including the SERENITY At-Home Phase 3 Trial for agitation associated with bipolar disorders or schizophrenia. It is headquartered at 555 Long Wharf Drive, 12th Floor, New Haven, CT 06511.

clinical researchclinical trials

Compiled from public sources

Related capabilities

Other processes offered by the shops that list AI-based drug re-innovation.

Browse all capabilities